🇺🇸 FDA
Pipeline program

Mometasone Furoate Nasal Spray, 50 mcg

AM-MMS-001

Phase 3 small_molecule completed

Quick answer

Mometasone Furoate Nasal Spray, 50 mcg for Seasonal Allergic Rhinitis is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amneal Pharmaceuticals
Indication
Seasonal Allergic Rhinitis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials